Skip to Main Content

Two of the nation’s largest pharmacies – CVS (CVS) and Walgreens (WBA) – are accused of overcharging consumers who used insurance to pay for some generic drugs and did not disclose that paying cash would be cheaper, according to separate lawsuits filed in federal courts this week.

In both suits, consumers contend the pharmacy chains made agreements with pharmacy benefit managers, or PBMs — which negotiate with drug makers for preferred insurance coverage on behalf of health plans — to sell certain medicines at a higher price if customers pay with insurance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.